NCT03697187View on ClinicalTrials.gov

Patient Registry to Evaluate the Real-world Safety of Ruconest®

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

June 30, 2018

Primary Completion Date

June 30, 2021

Study Completion Date

July 31, 2021

Conditions
Hereditary Angioedema
Interventions
DRUG

rhC1INH

Recombinant human C1 inhibitor

Trial Locations (1)

22030

The US Hereditary Angioedema Association, Fairfax

Sponsors
All Listed Sponsors
collaborator

US Hereditary Angioedema Association

UNKNOWN

lead

Pharming Technologies B.V.

INDUSTRY

NCT03697187 - Patient Registry to Evaluate the Real-world Safety of Ruconest® | Biotech Hunter | Biotech Hunter